Dr. Gregory Berk
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Gregory Berk
Dr. Gregory Berk is recorded as CEO at GT Biopharma, Inc. (GTBP). GT Biopharma, Inc. reported in an 8-K filed December 13, 2022 that Dr. Gregory Berk was terminated as President of Research & Development and Chief Medical Officer, effective December 8, 2022. The proxy statement of GT Biopharma, Inc. reports total compensation of $1,424,519 for Dr. Gregory Berk in fiscal 2021, including a base salary of $311,841. Disclosed compensation is on record for 2 fiscal years.
“Effective December 8, 2022, Dr. Gregory Berk, President of Research & Development and Chief Medical Officer, is no longer employed by the Registrant.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
GT Biopharma, Inc. (GTBP)
SEC 8-K
2021-04-23–2022-12-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GT Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Anthony Cataldo CEO
- Michael Breen CEO, Board Member
- Bruce Wendel Chairman
- Alan L. Urban CFO, Board Member
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Andrew Ritter Board Member
- Charles J. Casamento Board Member
- David C. Mun-Gavin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | GT Biopharma, Inc. (GTBP) | Former Interim Chief Executive Officer, President of Research & Development and Chief Medical Officer | $311,841 | $1,424,519 |
| 2020 | GT Biopharma, Inc. (GTBP) | Former Interim Chief Executive Officer, President of Research & Development and Chief Medical Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.